Alert: Regional Center has been Terminated. Termination Date: August 07, 2019.

BirchLEAF Miami 31 Regional Center Rating

Profile Completion:Not Rated
Projects Completion:Not Rated
Site Activity:Not Rated
Knowledge:Not Rated
Experience:1 project
I-924A Rating:Non-Transparent


BirchLEAF Miami 31 Regional Center
First Name
J. Bruce
Last Name
Contact Phone
Contact Email


100 S.E. 2nd Street, Suite 2330 Miami, FL 33131


  • Alachua




Viji DurgaBen Cummings Bruce Ricciuti

Last Update: May 11, 2020 04:37 AM

Regional Center was viewed 3047 times (total).

BirchLEAF Miami 31 Regional Center


BirchLEAF Miami 31 Regional Center was formed to provide debt investments through the U.S. EB-5 Immigrant Investor Pilot Program. The BirchLEAF Miami Life Science Fund, LP is managed by BirchLEAF Miami 31, LLC, its General Partner, that provided a $20 million loan financing for Building One of the University of Miami Life Science & Technology Park, a development of Wexford Science + Technology, LLC.

University of Miami Life Science & Technology Park (UMLSP)

The overall University of Miami Life Science & Technology Park project consists of an eight-acre site planned for development with a five-building, 1.65 million square foot potential development which will include biomedical research and development along with supporting activities. The UMLSP site is adjacent to the University of Miami Miller School of Medicine within the Miami Health District of the City of Miami. The UMLSP site fronts Miami-Dade’s major north-south and east-west traffic arteries, Interstate 95 and State Route 836. Information on the Life Science & Technology Park may be viewed at

BirchLEAF’s financing agreement is based on Building One of the UMLSP, a six-story life science/medical research building comprising approximately 252,000 rentable square feet. Construction of the facility commenced in Spring 2010, with the core and shell completed in June, 2011. The land that comprises the UMLSP is owned by the University of Miami. The University has leased the land on which Building One was constructed to Wexford under a 60-year ground lease.

The lead design architect for the Life Science Park’s Master Plan and Building 1 is Zimmer Gunsul Frasca (ZGF), a nationally recognized life science facility designer. Building 1 was designed to achieve a minimum LEED Silver certification and was constructed by The Whiting-Turner Contracting Company. Parking is provided by an adjacent surface lot of 2.8 acres.

Total project costs are approximately $107 million. Construction is funded through a combination of financing (Recovery Zone Facility Bonds, federal New Market Tax Credits, EB-5 funding and developer cash equity).

Job Creation & Economic Impact

An economic impact study pertaining to the proposed Regional Center was performed by The Jacob France Institute of the University of Baltimore. As indicated by the study, the funding of the University of Miami Life Science & Technology Park is projected to create approximately 1,595 jobs, on both a direct and indirect basis.

Project Investment Offering

BirchLEAF Miami Life Science Fund, LP offered up to 40 individual investment units to invest in Building 1 of the University of Miami Life Science & Technology Park project. The project was sold out and closed to new investors on December 31, 2010. In March 2012, all of the forty I-526 petitions had received USCIS approval.

Is the Regional Center a Public Agency, Government Entity or a Public/Private Partnership (EDC/EDA) affiliated or associated with one?


  • BirchLEAF Miami 31 All Sold Out of EB-5 Visas
  • Former affiliate of NYC Regional Center files suit, claiming firm stole confidential Chinese client list, thus saving millions in finder's fees for EB-5 investors in Atlantic Yards, other projects
BirchLEAF Miami 31 Regional Center screenshotBirchLEAF Miami 31 Regional Center screenshot


Regional Center ID number
Termination Date


Recent um


Overall Funding Needed:N/A (Mio)
EB-5 Funding Needed:N/A (Mio)

Regional Center EB-5 Quick Facts

Number of Approved I-526: N/A

Number of Approved I-829: N/A

Securities Disclaimer

This website is for informational purposes only and does not constitute an offer or solicitation to sell shares or securities. Any such offer or solicitation will be made only by means of an investment's confidential Offering Memorandum and in accordance with the terms of all applicable securities and other laws. This website does not constitute or form part of, and should not be construed as, any offer for sale or subscription of, or any invitation to offer to buy or subscribe for, any securities, nor should it or any part of it form the basis of, or be relied on in any connection with, any contract or commitment whatsoever. LLC and its affiliates expressly disclaim any and all responsibility for any direct or consequential loss or damage of any kind whatsoever arising directly or indirectly from: (i) reliance on any information contained in the website, (ii) any error, omission or inaccuracy in any such information or (iii) any action resulting therefrom.